Bausch + Lomb launched the enVista Aspire monofocal and toric IOLs in the European Union, according to a press release.Using intermediate optimized optics, the lenses offer a range of vision beyond ...

Ultra by Bausch and Lomb There are also toric (astigmatism correcting) silicone hydrogel lenses on the market: Silicone lenses have not been found to reduce the risk of bacterial keratitis for ...

Ultra by Bausch and Lomb Silicone lenses have not been found to reduce the risk of bacterial keratitis for contact lens wearers. Current research suggests that contact lens-related infections may be ...

Bausch + Lomb Corporation (NYSE:BLCO; TSX:BLCO), a global eye health company, has been navigating a complex market landscape ...

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy ...

City Therapeutics will develop a novel RNAi clinical candidate toward a specific disease target for intravitreal ...

InflammX’s pipeline includes an orally dosed therapeutic candidate targeting intermediate age-related macular degeneration ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its fourth-quarter and full-year 2024 financial ...

Bausch Health (BHC) Companies and Salix Pharmaceuticals acknowledged that the Centers for Medicare and Medicaid Services has selected XIFAXAN 550 mg tablets as one of the medicines for the second ...

LAVAL, QC / ACCESS Newswire / January 17, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its gastroenterology (GI) business, Salix Pharmaceuticals, today acknowledged that the Centers ...

We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, medical aesthetic devices, international pharmaceuticals and eye health, ...

There’s a lot riding on the latest Galaxy AI features headlining the Samsung Galaxy S25 Ultra, but after spending a short time with the phone I’m far more positive about it than I have been ...